Tripelennamine

Chemical formula: C₁₆H₂₁N₃  Molecular mass: 255.358 g/mol  PubChem compound: 5587

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
D04AA04 Tripelennamine D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc. → D04AA Antihistamines for topical use
Discover more medicines within D04AA04
R06AC04 Tripelennamine R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AC Substituted ethylene diamines
Discover more medicines within R06AC04

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 91-81-6
DrugBank Drug: DB00792
PubChem Compound: 5587
RxNorm Ingredient: 10847
SNOMED-CT Concept: 277020006
Tripelennamine (substance)
SNOMED-CT Concept: 373475006
Tripelennamine (substance)
UNII Identifier: 3C5ORO99TY
TRIPELENNAMINE

Medicines

Tripelennamine is an active ingredient of these brands:

Finland (FI)

  • ETONO as TRIPELENNAMINE HYDROCHLORIDE

Germany (DE)

  • AZARON as TRIPELENNAMINE HYDROCHLORIDE

Netherlands (NL)

  • AZARON as TRIPELENNAMINE HYDROCHLORIDE

Spain (ES)

  • AZARON as TRIPELENNAMINE HYDROCHLORIDE

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.